In the healthcare sector, Phoenix Life Sciences International Limited operates as a Biotech and Pharma company. It engages in research on organically produced plants such as cannabis and manufactures and distributes adaptive healthcare solutions. Its natural healthcare solutions are targeted at a wide array of conditions including diabetes, pain, cancers, and gastrointestinal problems. For the next five years, the company aims to expand its services to at least 2.5 million patients around the world.
The shares of the company are available for trading over the counter (OTC) under the ticker symbol “PLSI.” It has its headquarters in Denver, Colorado.
The healthcare sector has been traditionally stable. Companies in the biotech and pharmaceutical industry especially have experienced tremendous advances in recent years. The fast-growing cannabis industry has contributed in many ways to the growth of pharmaceutical and biotech firms. Many of them are investing millions in the medical cannabis market to develop cannabinoid products.
The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!
The prospect in the cannabis market is great and should be explored. And Phoenix Life Sciences International Limited is doing that.
LSI: A Successful Product of Strategic Partnerships
The most recent of Phoenix Life Sciences International Limited’s (PLSI) deals came through on June 4, 2019. The company announced it had signed an exclusive 25-year Diabetes Management Program deal with the Ministry of Health of the Republic of Vanuatu.
As part of the deal, it would also be granted a global medical cannabis export license. Vanuatu is estimated to have over 50,000 Type 2 diabetics and an expected 50,000 high-risk pre-diabetics. This deal is in furtherance of the company’s strategy of international market expansion.
Financials Indicate Long-Term Growth
For the nine months ended November 30, 2018, Phoenix Life Sciences International Limited did not report its revenues. However, it recorded a net loss of $3.3 million mainly due to an increase in operations expenses. Basic Earnings per Share (EPS) also decreased during the same period.
Following the 2018 merger and consolidation, to realise its plans to uplist to the OTCQB market, the company recently filed its 2017 and 2018 quarterly reports, and will also be subsequently making filings to stay current with its reporting requirements with the SEC. Uplisting will enable the company to access more funds for the execution of its next developmental stages.
The fundamentals of Phoenix Life Sciences International Limited are not presently attractive. The company is being burdened with rising operations expenses. This is expected as the company just passed through a major restructuring process and is focused on expanding to international markets.
The international expansion efforts should result in increased revenues. The uplisting would also create more access to funds. Both would contribute to long-term growth.
Moreover, at the current market price of $10.24, the company (OTC: PLSI) is trading far away from its 52-week high of $48.25, meaning a lot of upside potential. Hence, for the long-term investor, this might be a good time to buy.
Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!
Phoenix Life Sciences International (OTC: PLSI)
In the healthcare sector, Phoenix Life Sciences International Limited operates as a Biotech and Pharma company. It engages in research...
Phoenix Life Signs Exclusive Agreement with Vanuatu Government for 25-Year Diabetes Management Program and Global Medical Cannabis Export License
Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”, the “Company”), an adaptive healthcare solutions company, today announced that it has...
Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Acquires 46% Stake In Curative Cannabis And Agrees to Fund Cannabis Cultivation Facility To Produce Ultra Premium Cannabis
Auxly Cannabis Group Inc (OTCMKTS:CBWTF) has entered a deal to take over a 46% stake in Curative Cannabis. The company...
Canntrust Holdings Inc. (OTCMKTS:CNTTF) Receive Permission From The Town Of Pelham For Their Third Phase Construction
CannTrust Holdings Inc. (OTCMKTS:CNTTF) has announced that they have obtained the required permit to go on with the third phase...
Indiva Ltd (OTCMKTS:NDVAF) Announces 9.9% Equity Investment In Retailgo Inc.
Indiva Ltd (OTCMKTS:NDVAF) has announced that they are delighted to have finalized an Equity investment of 9.9% in RetailGo Inc....
Future Farm Technologies Inc (OTCMKTS:FFRMF) Plans To Begin Selling Of Cheery Wine Strain Hemp Seeds And Test Operation Of The Oil Extraction Equipment
Future Farm Technologies Inc (OTCMKTS:FFRMF) is planning to commence the selling of the elite cherry Wine hemp seeds by putting...
OrganiGram Holdings Inc (OTCMKTS:OGRMF) Sources Hemp With High Levels of CBD From 1812 Hemp
OrganiGram Holdings Inc (OTCMKTS:OGRMF) has entered into a supply pact with 1812 Hemp, an industrial hemp research company based in...
Kona Gold Solutions Inc (OTCMKTS:KGKG) Declares That They Have Acquired Gold Leaf Distribution
Kona Gold Solutions Inc (OTCMKTS:KGKG) has announced the acquisition of Gold Leaf distribution a newly established distribution company. The Florida...
CFN Media Group features Supreme Cannabis Company (OTCMKTS:SPRWF) as consideration for investors as their 2019 stock scales up
CFNB Media Group has announced a publication on Supreme Cannabis Company (OTCMKTS:SPRWF) as a licensed producer obsessed with quality. Supreme...
Village Farms International Inc (OTCMKTS:VFFIF) Leading Greenhouse Crop Protection And Announces Plans To List Its Common Shares On The NASDAQ Market
Village Farms International Inc (OTCMKTS:VFFIF) has announced that they have facilitated Health Canada Pest Management Agency to get approval for...